Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B‐cell non‐Hodgkin’s lymphomas and multiple myeloma
- 19 August 2001
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 39 (2) , 172-178
Abstract
Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B‐cell non‐Hodgkin’s lymphomas and multiple myeloma Aims: Nitric oxide synthases (NOS) are isoenzymes that catalyse the synthesis of nitric oxide (NO). The three main NOS isoforms are: NOS1 or neuronal, NOS2 or inducible, and NOS3 or endothelial. NO plays both physiological and pathological roles, depending on its rate of synthesis and concentration, cellular source and microenvironment. Apoptosis is an important biological factor in low‐grade lymphomas, and NO is able to prevent apoptosis. In‐situ expression of NOS and synthesis of NO have been shown in several malignant tumours, but not in lymphoid neoplasms. This study evaluates whether human B‐cell neoplasms express NOS isoforms, and nitrotyrosine (NY), which is usually interpreted as a marker of NO. Methods and results: We studied the expression of NOS‐IR isoforms and NY‐IR in 16 cases of B‐cell non‐Hodgkin’s lymphoma (NHL) (five follicle centre cell lymphoma, four small lymphocytic/CLL, and seven diffuse large cell lymphoma), and 10 cases of multiple myeloma (MM). NOS1 was expressed in 5/10 cases of MM, and 15/16 cases of NHL. NOS2 was detected in all cases of MM, and in 14/16 cases of NHL, whereas NOS3 was positive in 3/10 of MM and in only in 1/16 cases of NHL. The expression of NY‐IR was observed in 70% of MM cases, and in all cases of B‐cell NHL, in a dot‐like pattern in few tumour cells. Conclusions: B‐cell neoplasms express neuronal and inducible NOS, and nitrotyrosine. Taken together, our results suggest that B‐cell neoplasms can produce NO. The role of NO in the biology, diagnosis and prognosis of B‐cell neoplasms remains to be established.Keywords
This publication has 23 references indexed in Scilit:
- Inducible nitric oxide synthase in human diseasesClinical and Experimental Immunology, 1998
- Biological Tyrosine Nitration: A Pathophysiological Function of Nitric Oxide and Reactive Oxygen SpeciesArchives of Biochemistry and Biophysics, 1998
- The multifaceted roles of nitric oxide in cancerCarcinogenesis, 1998
- Nitric oxideThe International Journal of Biochemistry & Cell Biology, 1997
- Tumor Cell Nitric Oxide Inhibits Cell Growthin Vitro,but Stimulates Tumorigenesis and Experimental Lung Metastasisin VivoJournal of Surgical Research, 1996
- Nitric oxide synthase activity and expression in human colorectal cancerCarcinogenesis, 1996
- Third Place — Resident Basic Science Award 1995: Immunohistochemical Characterization of Nitric Oxide Synthase Activity in Squamous Cell Carcinoma of the Head and NeckOtolaryngology–Head and Neck Surgery, 1995
- Isoforms of nitric oxide synthaseBiochemical Pharmacology, 1995
- Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels.Journal of Clinical Investigation, 1995
- Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivationCell, 1994